Comment: Cost Comparison of Recombinant Human Erythropoietin and Blood Transfusion in Cancer Chemotherapy-Induced Anemia
- 1 September 1997
- journal article
- research article
- Published by SAGE Publications in Annals of Pharmacotherapy
- Vol. 31 (9) , 1094-1095
- https://doi.org/10.1177/106002809703100927
Abstract
No abstract availableThis publication has 5 references indexed in Scilit:
- Impact of therapy with epoetin alfa on clinical outcomes in patients with nonmyeloid malignancies during cancer chemotherapy in community oncology practice. Procrit Study Group.Journal of Clinical Oncology, 1997
- Cost Comparison of Recombinant Human Erythropoietin and Blood Transfusion in Cancer Chemotherapy-Induced AnemiaAnnals of Pharmacotherapy, 1997
- Prediction of response to erythropoietin treatment in chronic anemia of cancer [see comments]Blood, 1994
- Quality of life in chronic anemia of cancer during treatment with recombinant human erythropoietinCancer, 1994
- Recombinant Human Erythropoietin Therapy for Anemic Cancer Patients on Combination ChemotherapyJNCI Journal of the National Cancer Institute, 1993